Navigation Links
TravelMax and Reflectx Awarded The Joint Commission - Gold Seal of Approval(TM)
Date:10/20/2009

LAKE MARY, Fla., Oct. 20 /PRNewswire/ -- TravelMax and Reflectx Services national healthcare staffing companies have achieved the Gold Seal of Approval(TM) for healthcare staffing services. Both companies underwent on-site reviews of their compliance programs, meeting national standards that address how staffing firms determine the qualifications and competency of their staff.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091020/PH95728 )

"Healthcare organizations that contract with TravelMax and Reflectx can look to this certification as an assurance that both companies demonstrate a commitment to providing and continuously improving quality services," says Michele Sacco, M.S., executive director, Health Care Staffing Services Certification, Joint Commission.

The ongoing shortages of rehabilitation therapists, registered nurses, pharmacists, and other healthcare professionals have forced healthcare organizations to increasingly fill positions with temporary workers through contractual arrangements with staffing firms like TravelMax and Reflectx. The Joint Commission's certification program, launched in October 2004, offers an independent evaluation of a staffing firm's abilities to provide competent staffing services.

"Certification recognizes our dedication to providing physical and occupational therapists, nurses, pharmacists, and other allied professionals that are qualified to provide safe, high-quality care to patients," says Daryl Dixon, Division President. "We are proud to receive The Joint Commission's Gold Seal of Approval(TM). We recognize and value that The Joint Commission sets standards that are not only good for patient, but also good for business."

About The Joint Commission

Founded in 1951, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in healt
'/>"/>

SOURCE Maxim Healthcare Services
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Evosys, a Major Player in the Oracle E-Business Suite Implementation, Support and Consultancy Services Domain, has Recently Been Awarded Oracles Certified Advantage Partner Status
2. International SOS Awarded TRICARE Overseas Program Contract
3. SRI International Awarded a Department of Defense Laboratory-Clinical Transition Grant to Advance SRIs Novel Anticancer Agents for Prostate Cancer Treatment
4. Portico Healthnet Awarded $988K to Launch MN Coalition for Kids Health Coverage
5. Big Top Cupcake(TM) Brand Awarded With Guinness World Record For Worlds Largest Cupcake
6. Global Team for Local Initiatives Awarded $387,000 by USAID: New Model for Indigenous Health in Ethiopia
7. Case Western Reserve awarded $1.57M for corneal infection research
8. Galenea Awarded RC1 Challenge Grant to Develop Predictive In Vivo Models of Cognition
9. USC neuroscientists awarded $9 million to map gene expression during human brain development
10. $16.8 million grant awarded to develop platelet recovery treatments
11. The Ambrosia Treatment Centers Awarded Gold Seal of Approval by the Joint Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Kleritec, Inc. announced the addition ... http://www.kleritec.com . In the recent expansion Kleritec ... activities packages for pre-school and day care providers. The ... to aid teachers across the United States the ability ... , Included in the art and activities packages is ...
(Date:6/19/2013)... York, NY (PRWEB) June 19, 2013 Citi Bike ... There’s no way for Dr. David Perna to know for sure ... service, but he’s happy that they’ll have the option. In ... healthier lives—especially if it might also make it more convenient for ... Dr. Perna is the Director of Complimentary Alternative Medicine at Back ...
(Date:6/19/2013)... a major international study led by researchers at The ... therapy ibrutinib continues to show remarkable promise for the ... , The most recent interim findings of the 18-center ... New England Journal of Medicine . Previous interim findings ... Society of Hematology Annual Meeting and Exposition. , ...
(Date:6/19/2013)... as many emergency department visits if their primary care ... days a week, according to new research from child ... Hopkins University. , The new study was published online ... and will be presented at the AcademyHealth Annual Research ... understanding where primary care practices and medical home programs ...
(Date:6/19/2013)... Nearly 70 percent of Americans are on ... half take two, Mayo Clinic researchers say. Antibiotics, ... their study found. Twenty percent of patients are ... the findings, published online in the journal ... audio and video of Dr. Jennifer St. Sauver ...
Breaking Medicine News(10 mins):Health News:Kleritec Announces Addition of Educational Products. 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2
... ... a workshop on Dried Blood Spot Sampling in the Pharmaceutical Industry: Methodology, Implementation and Best ... ... Drug Information Association (DIA) , in cooperation with PhRMA, will host a workshop on ...
... Fla., Nov. 13 Many Americans suffer from bipolar disorder ... there is another way to cope with the illness that ... of Darkness: A personal journey of embracing the bipolar opportunity" ... who was diagnosed bipolar at age 17 -- presents a ...
... CARY, N.C., Nov. 13 Cornerstone Therapeutics Inc. (Nasdaq ... developing and commercializing significant products primarily for the respiratory ... Andrew K. W. Powell, Esq. Executive Vice President, General ... will join the Company,s executive management team and manage ...
... ... published independent clinical study on Vemma, its physician formulated liquid supplement, ... (Volume 57, Number 19, October 14, 2009). The clinical study ... Product in Humans” found that Vemma is highly bioavailable, showing an ...
... ... for Wellbeing, the subscription course is aimed at optimizing health goals , ... Draper, UT (PRWEB) November 13, ... program called ZriiAware: Grow Younger, Live Longer , with the intention of helping ...
... PORTLAND, Ore. Nov. 12 Regence BlueCross BlueShield has ... the American Heart Association,s Start! movement for helping employees ... and employee wellness are important priorities at Regence," said ... providing the best workplace environment possible and helping our ...
Cached Medicine News:Health News:,DIA/PhRMA Workshop to Explore Dried Blood Spot Sampling Implementation and Advances, 2Health News:,DIA/PhRMA Workshop to Explore Dried Blood Spot Sampling Implementation and Advances, 3Health News:'Living Out of Darkness: A personal journey of embracing the bipolar opportunity' 2Health News:'Living Out of Darkness: A personal journey of embracing the bipolar opportunity' 3Health News:Cornerstone Therapeutics Appoints General Counsel 2Health News:Cornerstone Therapeutics Appoints General Counsel 3Health News:Independent Clinical Study Finds Vemma is Highly Bioavailable Showing Increase in Vitamins and Antioxidants in the Blood* 2Health News:Independent Clinical Study Finds Vemma is Highly Bioavailable Showing Increase in Vitamins and Antioxidants in the Blood* 3Health News:Independent Clinical Study Finds Vemma is Highly Bioavailable Showing Increase in Vitamins and Antioxidants in the Blood* 4Health News:Zrii Implements New Online Lifestyle Program, ZriiAware: Grow Younger, Live Longer 2Health News:Regence Recognized as an American Heart Association Start! Fit-Friendly Company 2Health News:Regence Recognized as an American Heart Association Start! Fit-Friendly Company 3
(Date:6/19/2013)... The Physician-Patient Alliance for Health & Safety recently released three ... urgently address this issue has been emphasized by The ... device alarm safety in hospitals." According to The Joint Commission ... there were 98 alarm related events reported, of which: ... resulted in permanent loss of function (13%) , 5 ...
(Date:6/19/2013)... NEW YORK , June 19, 2013   ... dedicated to finding a cure for brain cancer, today ... ) a grant to support the clinical investigation of ... a recurrent high grade glioma brain cancer (Grade 3 ... company developing novel treatments for advanced cancer, with an ...
(Date:6/19/2013)...   Nektar Therapeutics (Nasdaq: NKTR ) ... (HAL) study for NKTR-181, a first-in-class, opioid analgesic ... This slow rate of entry is designed to reduce the ... to current opioid analgesics. 1 In the study data ... placebo in "drug liking" and "feeling high" scores and had ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
... Study Showed 11 Percent Fewer RA Patients,Reported ... Therapy,Compared to Methotrexate Alone, BARCELONA, Spain, June ... one of the most common causes of,disability ... today show that,rheumatoid arthritis (RA) patients treated ...
... Influenza Conference, HIGH WYCOMBE, England, June 18, 2007 ... new flu vaccine has the,potential to protect against ... presented today by PepTcell, at the 2007,Options for ... Canada. , The pre-clinical results, which will be ...
Cached Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
For rigid cystoscopes and rigid-, and semi-rigid ureteroscopes, these forceps have an integral handle design and a diameter of 5 Fr with a working length of 58 cm....
Fulgurating Electrode, 2 F...
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: